Testing effectiveness (Phase 2)WithdrawnNCT05411107
What this trial is testing
Oral Iloprost for the Prevention of Lung Cancer In Former Smokers
Who this might be right for
Bronchial Epithelial DysplasiaChronic Obstructive Pulmonary DiseaseLung Carcinoma+3 more
National Cancer Institute (NCI)